Back to Search
BRYAN SCHNEIDER, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1811953433IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology Physician
Internal Medicine — Medical Oncology
Code: 207RX0202X
01053603A(IN)
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
01053603(IN)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
INDIANA UNIVERSITY SCHOOL OF MEDICINE
Class of 1999
Research & Publications (20)
Anti-VEGF therapy as adjuvant therapy: clouds on the horizon?
PMID 19519950·Breast Cancer Res·2009
7-preclinical
Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashes.
PMID 18785001·Breast Cancer Res Treat·2009
8-other
Triple-negative breast cancer: risk factors to potential targets.
PMID 19088017·Clin Cancer Res·2008
6-review
Association of polymorphisms of angiogenesis genes with breast cancer.
PMID 17891484·Breast Cancer Res Treat·2008
8-other
Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.
PMID 18824714·J Clin Oncol·2008
3-trial
A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-alpha2b in patients with solid tumors.
PMID 16733646·Cancer Chemother Pharmacol·2007
3-trial
Drug insight: VEGF as a therapeutic target for breast cancer.
PMID 17327858·Nat Clin Pract Oncol·2007
6-review
Analysis of angiogenesis genes from paraffin-embedded breast tumor and lymph nodes.
PMID 16505966·Breast Cancer Res Treat·2006
8-other
Outcome of patients with residual germ cell or non-germ cell malignancy after resection of primary mediastinal nonseminomatous germ cell cancer.
PMID 15051766·J Clin Oncol·2004
8-other
Phase II study of gemcitabine plus docetaxel in advanced pancreatic cancer: a Hoosier Oncology Group study.
PMID 14657595·Oncology·2003
3-trial
Normative voice range profiles in vocally trained and untrained children aged between 7 and 10 years.
PMID 19303739·J Voice·2010
8-other
Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer.
PMID 19225720·Invest New Drugs·2009
3-trial
[Justification of repeated animal experiments and determination of the required number of animals according to the German Animal Protection Act].
PMID 19634514·Arzneimittelforschung·2009
7-preclinical
Smoking differently modifies suicide risk of affective disorders, substance use disorders, and social factors.
PMID 18558438·J Affect Disord·2009
4-observational
Substance use disorders as risk factors for suicide in an Eastern and a Central European city (Tallinn and Frankfurt/Main).
PMID 19185355·Psychiatry Res·2009
8-other
Clinical use of an herbal-derived compound (Huperzine A) to treat putative complex partial seizures in a dog.
PMID 19616481·Epilepsy Behav·2009
5-case
Executive ability and physical performance in urban Black older adults.
PMID 18650058·Arch Clin Neuropsychol·2008
8-other
Viral vectors, animal models and new therapies for Parkinson's disease.
PMID 18585946·Parkinsonism Relat Disord·2008
6-review
Frequency of contamination of coagulation factor concentrates with novel human parvovirus PARV4.
PMID 18565125·Haemophilia·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 535 BARNHILL DR, RT 473
INDIANAPOLIS, IN 46202 - Phone
- (317) 274-5112
Quick Facts
- NPI
- 1811953433
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 27
- Publications
- 20
Are you this provider?
Claim Your Profile